chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 1st vaccine I started to have a little lower back, bilateral hip & groin pain.; After 1st vaccine I started to have a little lower back, bilateral hip & groin pain.; pain increased as time went on; This is a spontaneous report from a contactable Nurse, the patient. This is the first of two reports and captures events experienced after the first vaccine.   A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL9264,), via an unspecified route of administration on 28Jan2021 at 14:00 (at the age of 67-years-old) as a single dose in the right arm for COVID-19 vaccination. Medical history includes COPD and a history of failed lumbar fusions due to scoliosis. This was further reported as about three surgeries in the lumbar area for fusions due to scoliosis in the past years. The last one was about five years ago. Prior to the vaccination, the patient was not diagnosed with COVID-19. The vaccine was administered to the patient at a Health Clinic . Concomitant medications included roflumilast (DALIRESP), montelukast sodium (SINGULAIR), duloxetine (MANUFACTURER UNKNOWN), loratadine (MANUFACTURER UNKNOWN) and "SPIRI,"  all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took meperidine (DEMEROL) and experienced allergy. The patient reported that after the first vaccine, she started to have a little lower back, bilateral hip and groin pain on 30Jan2021. The pain increased as time went on (dates not specified). The patient mentioned having to use "narcotics, heat, ice, Tylenol or Ibuprofen" (dates not specified) to control pain. The clinical outcomes of the events low back pain, groin pain and pain aggravated were reported as not recovered.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.    Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021223014 same patient/drug, different vaccine dose/event
Follow-up information pertaining to the patient's recovery status has been received. Information regarding Prevnar was received from a healthcare professional regarding a female patient who had a positive test result for streptococcal pneumoniae. At 15 months of age, the patient received the fourth dose on 05-Jun-2006. The patient also received the first dose of M-M-R on 05-Jun-2006. On 05-Jun-2006 the patient received her 4th dose of Prevnar. Within 12 hours after vaccination on 06-Jun-2006, the patient was hospitalized with a fever of 103 deg. F. Testing was positive for streptococcal pneumoniae. It was noted that the "test report was sent to the state to see what strain it is". The patient was treated with unspecified intravenous antibiotics. The patient recovered.
Upon withdrawal of needle, a large, dark, raised bruise appeared roughly 1/4 inch at peak. After several minutes, the size decreased but it still remained raised and hard to touch.
Chills, headache,upset stomach and generalized myalgia-ache all over feeling
syringe failed and the patient did not receive the full dose; syringe failed and the patient did not receive the full dose; A spontaneous report was received from a nurse concerning a 69-year-old, patient, who received Moderna's COVID-19 vaccine (mRNA-1273) experienced event like syringe failed and the patient did not receive the full dose.  The patient's medical history was not provided. Concomitant medications were not reported.  The patient received their first of two planned dose of mRNA-1273 on 27-jan-2021. On 27-Jan-2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unkown) intramuscularly for prophylaxis of COVID-19 infection.    On 27 Jan 2021, the patient experienced event like syringe failed and the patient did not receive the full dose.  Action taken with mRNA-1273 in response to the events was not reported.    The outcome of the event, syringe failed and the patient did not receive the full dose is unknown.; Reporter's Comments: This report refers to a case of a 69-year-old patient of unknown gender who experienced nonserious unexpected events of Syringe issue and Incorrect dose administered for mRNA-1273, lot # unknown, with no associated adverse events. The syringe failed and the patient did not receive the full dose.  Event considered resolved.
Initially noticed redness and swelling of her right upper arm. Symptoms continued to increase despite cool compresses and Tylenol. Developed warmth and spreading erythema down below elbow. Patient taken to ER on 1/26/11 to be evaluated and decision was made that patient had celluliltis and needed IV antibiotics. Decision was made to give IV Vancomycin and patient subsequently developed redman's syndrome. Patient was transferred to another Hospital and started on IV clindamycin and admitted overnight. Patient was sent home with 7 days of po clindamycin. Patient was seen in the office for follow up on 1/28/11 and erythema and swelling were resolving well.
16JUL96 3hr p/vax reports sore arm, shoulder & knees;12hr p/inj pt had severe vomiting;stomach cramps, diarrhea, h/a, dizziness & entire body aches;every bone in body hurt;pt came into ER on 18JUL96 presented to ER for tx;
About 30 minutes after the vaccine was administered, my mouth began to feel strange. Had a slight metallic taste to my mouth and my mouth also felt a little dry. About 10 minutes later, my mouth started to feel slightly numb. Then my whole face, neck, and inside my mouth felt slightly numb. Not completely numb. I was still able to breath and swallow just fine. The numb feeling  lasted close to 24 hours.
Skin lesion on anterior chest wall in previously normal skin, rapid growth, biopsied, confirmed with second opinion, and diagnosis found to be Mycosis fungoides. Have had two biopsies. Last a week ago to completely resect the cancer. Further referrals to Oncologists, Radiation Oncologists/other pending.
Breakthrough case admission after three vaccines pfizer 3/11/21  Lot# EN6201;  Pfizer 4/1/21 Lot# Ew0150;  Pfizer 12/10/21 Lot# FD0809
Massive hair loss.  Started gradually 5 months post shot, then massive hair loss 6 months post shot still continuing 9 months later.  I've lost 50+% of my hair.  It is entire scalp, not localized.  It continues to come out massively daily.  My scalp now shows with a thin layer of hair when I previously had long luxurious head full of hair.  I've had my thyroid checked along with a complete blood work-up.  I've been to a Dermatologist who could give no medical diagnosis for my massive hair loss (it was sudden and extreme) and said it could have been from the vaccine since that was my only event leading up to it.    Recently doing research on this, I see I'm not alone in this horrific side effect.
Onset of left shoulder pain 11/17/99, then vesicular rash on left arm, (not in a dermatome pattern).
Slight tightness  in the chest area after waking up the following morning. Tightness duration was about  4 hours. It resolved itself in the afternoon by 4pm
Lightheadedness; facial redness; flushing; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Lightheadedness), ERYTHEMA (facial redness) and FLUSHING (flushing) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.    Co-suspect product included non-company product HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]) for an unknown indication.    Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced DIZZINESS (Lightheadedness), ERYTHEMA (facial redness) and FLUSHING (flushing). At the time of the report, DIZZINESS (Lightheadedness), ERYTHEMA (facial redness) and FLUSHING (flushing) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment include water.
Headache left arm/hand swelling, fatigue, weakness, swollen glands, chills Narrative:
I started to have a little fogginess around 1 32 o?clock then after that I started having severe pains in my legs and my knees my whole body hurt especially in the legs I could not walk the following day I like was out of breath very winded and mind you I am a very healthy 38-year-old woman I work out on a regular basis I am very active with my kids I am five for 128 pounds it felt like my legs had to be stretched out forever it was the weirdest pain I can?t even describe it also I was very itchy and I looked and I did not have hives it was especially in my hands and my feet but I definitely felt spaced out for two full days I ran a slight low-grade fever I was very fatigued could not do anything I would go to the bathroom and I would have to come right back to bed my arm is sore but it almost just feels like a sore muscleI did take Motrin Tylenol nothing helped I had to sit on a chair with my legs straight out and exercise them because the pain was so intense in my muscles very odd but thanks for having this page and let me tell you my concerns so I?m not sure what kind of reaction I had other than that I was breathing fine I was just so tired and cannot walk because the pain thanks for your time
Patient called a couple of days after vaccine administration to say that the area around the vaccination site had turned red and hot and  itchy.  She had gone to bed and remained there for the rest of the day.  Then felt better when she got up and redness slowly went away,.
"Covid Arm" red blotch and itchy a week after receiving the first does of moderna
14 yo female patient brought to the ED by her mom for sudden 9/10 sharp, non-radiating chest pain and palpitations. The pain started 8/30 around 6pm, with no identifiable trigger.  Symptoms continued despite taking tylenol pills. She had 4 episodes of non-bloody non-bilious vomiting and headache. Mother called an ambulance and was taken to the ED around 9pm. Symptoms resolved by 01:00am.  ED course:  In the ED, patient afebrile with marked tachycardia heart rate in 130s to 140s, initial suspicion for pulmonary embolism, emergent CT scan ruled out PE Labs as follows: initial troponin of 17 repeat of 30, EKG with persistent sinus tachycardia, CBC with a white count of 12.4 thousand hemoglobin of 12.3 hematocrit of 44.9, platelet count of 317 neutrophils of 90% elevated, normal prothrombin time of 12, normal D-dimer, mildly elevated proBNP of 170, CRP of 0.9 normal, COVID antibodies negative,  Patient was admitted to the Pediatric Inpatient Floor on 8/31 for continued monitoring.  On admission to the floor patient persistently tachycardic with complaints of palpitations, also with complaints of headache, repeat troponin trending up increased to 88. Cardiology consulted, performed an echocardiogram that did not show evidence of myocarditis or pericarditis. Patient received IV fluids.  Updated labs on 8/31:  D-dimer 270 BMP: Na+ 138, K+ 4.2, HCO3- 23, Cl- 103, BUN/Creatinine 10/1,  Anion Gap 12 Troponin (trended every 4-6 hours): 17, 30, 88, 71 Utox/UA normal  8/31 Echocardiogram Results:  Initial echocardiogram for possible myo-pericarditis. No structural defects, normal valvular function, Qualitatively normal right ventricular size and systolic function, Normal left ventricular size and systolic function, No evidence of significant pulmonary hypertension, No significant pericardial effusion.   Hospital Course on 9/1:  Patient was feeling much better, denied any symptoms and was resting comfortably. Her troponins trended downwards and she was cleared to be discharged with a plan to follow up with her cardiologist and primary care physician.  Troponins on 9/1: 52, 49, 43 CBC: within normal limits T3/T4/TSH: within normal limits
Red, raised itchy rash on arms and back. PT also reported pain and swelling of feet. No obvious reaction at injection site. Redness and urticarial wheals on arms, legs, hands, feet (palms and soles) and back.
Palpitations started when lying down at night, at early morning.   Symptoms slowly subsided until 2nd dose of vaccine a month later.  Palpitations harder and longer than first dose, when lying down but also experiencing in upright position. Shortness of breath also present.   6 weeks later and although lesser in intensity and frequency, still experiencing palpitations when lying down
Ear and sinus infection; Ear and sinus infection; eye itchiness; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Ear and sinus infection), EAR INFECTION (Ear and sinus infection) and EYE PRURITUS (eye itchiness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy (eye itchiness).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Ear and sinus infection), EAR INFECTION (Ear and sinus infection) and EYE PRURITUS (eye itchiness). At the time of the report, SINUSITIS (Ear and sinus infection), EAR INFECTION (Ear and sinus infection) and EYE PRURITUS (eye itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products reported.  Patient reported that  she would  start antibiotics after first dose on 1 apr 2021.
This is a spontaneous report received from a contactable reporter(s) (Nurse), Program ID: A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLAMMATION (non-serious), outcome "recovered", described as "Inflammatory reaction". Additional information: The patient had inflammatory reaction for three days after his covid-19 vaccine, but then was fine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : PFIZER INC-202201104380 same suspect vaccine, different patients;
C/O 'EXTREME FATIGUE' Narrative:  w/ C/O extreme fatigue upon awakening the day after, advised to call 911 like any other emergency or report to ED for worsening conditions.
temperature exposure > 24 hours; administered expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (temperature exposure > 24 hours) and EXPIRED PRODUCT ADMINISTERED (administered expired vaccine) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History was reported.     On 20-Aug-2021 at 11:52 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (temperature exposure > 24 hours). On 20-Aug-2021, EXPIRED PRODUCT ADMINISTERED (administered expired vaccine) had resolved. At the time of the report, PRODUCT STORAGE ERROR (temperature exposure > 24 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were mentioned. reporter stated that: The vaccine vial was opened on 8/11/21 and one dose was given to a patient. The vail was never removed from the refrigerator after that day or wasted/disposed of.  The vial was accidently used for vaccines given on 08/20/2021.   Most recent FOLLOW-UP information incorporated above includes: On 04-Sep-2021: Follow-up received  added new reporter, patient demographics, date of start of suspect drug, dose number, anatomical location of vaccine administered  & event: administered expired vaccine, No side effect / adverse events. On 08-Sep-2021: Follow-up received contains additional significant followup appended. date of birth was updated.
Pt C/O syncope in the observation area while sitting in a chair. She struck her forehead and bridge of nose resulting in abrasions on forehead and bridge of nose. Fall was witnessed by other vaccine recipients in the observation area. Nurses assisted the pt within 1 minute. Pt was A&O X 4 after < or = to 2 minutes of the fall. Medical HX: Pt stated she returned from out of the country 2 days prior to her vaccination. Pt stated allergy to PNC. Pt stated that she had passed out on other occasion r/t to low BG. Interventions: Ice pack applied to forehead. C-Spine support was maintained by nurses until EMS arrived and transported the pt. Home Medications: Pt stated no routine prescribed medications. OTC dietary supplements only: Vitamins C and D and multivitamin only. Vital Signs: 1100; B/P 122/92; SPO2: 96% on room air; HR: 100 BPM; Respiratory Rate: 16 per minute.
Arm at injection site was sore to the touch for over a month.  It was never noticeably swollen or throbbing, just sore to the touch, and my muscle there has been destroyed somewhat.  There is a definite dent in my muscle.
Suspected vaccination failure; I had the shingles shot and still got shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter reported for himself or herself. The age at vaccination was not reported. The reporter stated that, after shingles shot still got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.
Sx onset: 7/12/21 cough, runny nose, sore throat, fever, headache, loss of smell & loss of taste. Tested for COVID-19 on 7/15/21 which returned as positive.
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (hot extremely itchy), VACCINATION SITE PRURITUS (red, hot, raised, extremely itchy red "spot/circle" at the injection site), VACCINATION SITE SWELLING (puffy and swollen) and VACCINATION SITE ERYTHEMA (Red mark on right arm, red, hot, raised, extremely itchy red "spot/circle" at the injection site.) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The patient's past medical history included Skin rash. Concurrent medical conditions included Drug allergy (Sulfur medications) and Seasonal allergy (Hay fever allergies). Concomitant products included MULTIVITAMINS [VITAMINS NOS], ASPIRIN [ACETYLSALICYLIC ACID] and CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM SUPPLEMENT WITH VITAMIN D) for an unknown indication. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot extremely itchy), VACCINATION SITE PRURITUS (red, hot, raised, extremely itchy red "spot/circle" at the injection site) and VACCINATION SITE ERYTHEMA (Red mark on right arm, red, hot, raised, extremely itchy red "spot/circle" at the injection site.). On 17-Jan-2021, the patient experienced VACCINATION SITE SWELLING (puffy and swollen). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Vaccination site pruritus, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (hot extremely itchy), VACCINATION SITE PRURITUS (red, hot, raised, extremely itchy red "spot/circle" at the injection site), VACCINATION SITE SWELLING (puffy and swollen) and VACCINATION SITE ERYTHEMA (Red mark on right arm, red, hot, raised, extremely itchy red "spot/circle" at the injection site.) had resolved. Second event after second shot: 3 days later woke up with red, hot, reased and not as itchy red "spot" not as defined a circle as the first one. Took Bendaryl and iced it as needed for about 3 days. It eventually went away in about 2 weeks. (could still see a shadow of the "spot" wasn't hot, or raised or itchy. This case was linked to MOD-2021-089784 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Event details updated, patient details updated, concomitant medication list updated. On 28-Apr-2021: patient date of birth and phone number details was  provided in TCR.
Pain underneath left arm; Swollen gland underneath the left arm; Ran a fever; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen gland underneath the left arm), PYREXIA (Ran a fever) and VACCINATION SITE PAIN (Pain underneath left arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 016B27L) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced PYREXIA (Ran a fever). On 02-May-2021, the patient experienced LYMPHADENOPATHY (Swollen gland underneath the left arm). On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain underneath left arm). On 04-May-2021, PYREXIA (Ran a fever) outcome was unknown. At the time of the report, LYMPHADENOPATHY (Swollen gland underneath the left arm) and VACCINATION SITE PAIN (Pain underneath left arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not reported. Treatment medications was not reported. Patient took pain and inflammatory medication to help with symptoms.
PT REPORTED TINGLING OF THE TONGUE AND SWELLING OF THE LIPS WITHIN 5 MINUTES OF SHOT ADMINISTRATION. 25MG OF LIQUID DIPHENHYDRAMINE WERE ADMINISTERED. PT REPORTED A LESSENING OF SYMPTOMS WITHIN 15 MINUTES AND LEFT STATING HE FELT BETTER.
Arm soreness and fever started the day after vaccination.  On Nov. 6, patient noted redness and swelling around injection site and symptoms remained to this day.
Pain in shoulder blades closer to left side feels like a catch following fever of 100.5 or greater difficulty breathing and Sob. Tiredness muscle aches joint pain and headache. When taking a deep breath there is excruciating pain in back and in left shoulder and numbness in left arm. Im so weak I feel so bad it?s so bad I feel like I?m going to die. It?s bad.
The resident received his COVID-19 Moderna vaccination on 2/6/2021 2:11 pm and expired on 2/7/2021 at 6:04 am.  There were no signs or symptoms of vaccination reaction leading up to death.